Titan Pharmaceuticals Inc.

07/22/2025 | Press release | Distributed by Public on 07/22/2025 15:04

Proxy Statement - Business Combination (Form DEFM14A)

Titan Pharmaceuticals Inc. published this content on July 22, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on July 22, 2025 at 21:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io